7th IPF Summit: Advancing Insights and Collaboration in Pulmonary Fibrosis Research and Therapeutic Development Read more
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union Read more
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases Read more
Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism Read more
Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes Read more
European Commission approves Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA) Read more
AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI) in Ulcerative Colitis Read more
FDA Approves Veklury (Remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment Read more